MOUNTAIN

📅 Upcoming

🕒 Recent(90d)

News

• As Maui recovers from devastating fires, a study offers vision for new rural health model
  A study of the long-term health impact of the Lahaina wildfires is inspiring a new model for disaster recovery and support.
  stat · 20d ago
• STAT+: Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and more
  U.S. judge blocked a Colorado state panel from placing a cap on the price of Amgen's blockbuster drug Enbrel
  stat · 1mo ago
• STAT+: Pharmalittle: We’re reading about fewer pharma investments in Germany, growing U.S. layoffs, and more
  Eli Lilly is halving its originally planned investment in the production of weight loss syringes in Germany in response to a cost-cutting law
  stat · 2mo ago
• Senior NIH scientist, research fellow charged with bringing deactivated mpox virus into U.S.
  A senior NIH scientist and his research fellow were charged with smuggling vials of deactivated mpox virus into the country from Africa and lying about it.
  stat · 2mo ago
• Opinion: What can ‘blue zones’ really teach us about aging?
  Have you heard about blue zones where people tend to live much longer? They’re more complicated than they might sound.
  stat · 3mo ago
• Remembering J. Craig Venter: a relentless scientist who changed biotech — and was all too easily misunderstood
  J. Craig Venter, the scientist whose relentless ambition helped turn genetics from an artisanal trade into an industrialized information machine, died at 79.
  stat · 3mo ago
• Teva nabs experimental Tourette drug in $700M Emalex buyout
  A Jefferies analyst argued the deal — Teva’s largest in a decade — “makes sense” given the synergies between Emalex and the pharmaceutical giant’s neurology business.
  biopharma_dive · 3mo ago